What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Detlef Zillikens focuses on Immunology, Autoantibody, Bullous pemphigoid, Pemphigoid and Antibody.
His Immunology research is multidisciplinary, incorporating perspectives in Molecular biology, Ectodomain and Keratinocyte.
His research integrates issues of Pemphigus, Autoimmune disease and Pathology in his study of Autoantibody.
His Bullous pemphigoid study also includes fields such as
- Antigen which is related to area like Pathogenesis,
- Epitope and related Virology.
His Pemphigoid study incorporates themes from Laminin, Indirect immunofluorescence and MEDLINE.
While the research belongs to areas of Antibody, Detlef Zillikens spends his time largely on the problem of Immune system, intersecting his research to questions surrounding Proinflammatory cytokine, Receptor and Immunopathology.
His most cited work include:
- The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators (536 citations)
- Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus (340 citations)
- The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile (307 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Autoantibody, Bullous pemphigoid, Dermatology and Pemphigoid.
His work carried out in the field of Autoantibody brings together such families of science as Autoimmune disease, Epitope, Antigen, Pathology and Pemphigus.
In his research, Desmoglein 3 is intimately related to Pemphigus vulgaris, which falls under the overarching field of Pemphigus.
His Bullous pemphigoid research is multidisciplinary, incorporating elements of Dermoepidermal junction, Ectodomain and Dermatitis herpetiformis.
His Dermatology research includes themes of Immunoadsorption and MEDLINE.
His Epidermolysis bullosa acquisita research incorporates elements of Epidermolysis bullosa and Immune system.
He most often published in these fields:
- Immunology (43.02%)
- Autoantibody (40.70%)
- Bullous pemphigoid (33.89%)
What were the highlights of his more recent work (between 2018-2021)?
- Bullous pemphigoid (33.89%)
- Autoantibody (40.70%)
- Pemphigoid (23.75%)
In recent papers he was focusing on the following fields of study:
His main research concerns Bullous pemphigoid, Autoantibody, Pemphigoid, Dermatology and Immunology.
His research on Bullous pemphigoid also deals with topics like
- Pemphigus vulgaris which connect with Rituximab,
- Retrospective cohort study which connect with Gastroenterology.
The various areas that Detlef Zillikens examines in his Autoantibody study include Immunoglobulin G, Direct fluorescent antibody, Antigen, Internal medicine and Complement fixation test.
His Pemphigoid research is multidisciplinary, relying on both Skin pathology, Pathology, Epidermolysis bullosa acquisita, Gynecology and Pemphigus.
His studies deal with areas such as MEDLINE and Virology as well as Pemphigus.
In his study, Cohort is inextricably linked to Disease, which falls within the broad field of Immunology.
Between 2018 and 2021, his most popular works were:
- Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. (32 citations)
- IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. (30 citations)
- Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema (22 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His scientific interests lie mostly in Pemphigoid, Bullous pemphigoid, Autoantibody, Immunology and Dermatology.
His Pemphigoid research integrates issues from Pemphigus, Epidermolysis bullosa acquisita, Family medicine and Pathology.
His Bullous pemphigoid research is multidisciplinary, incorporating perspectives in Serology, Overall survival, Antigen and Programmed cell death.
His Autoantibody research is multidisciplinary, incorporating elements of Skin pathology, Adverse effect, Pharmacology, Low molecular weight heparin and Complement fixation test.
His research on Immunology frequently connects to adjacent areas such as Disease.
His work on Pemphigus vulgaris as part of general Dermatology study is frequently connected to Health insurance, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
